WELCOME TO BIOSENSORS

our news

BioFreedom proven in LEADERS FREE for Ultra-short DAPT

August 31, 2018 | News | BioFreedom
Freedom to treat with 1 month DAPT - Proven for ultra-short DAPT in the LEADERS FREE study, BioFreedom was more safe and effective than a BMS in high bleeding risk patients
READ MORE

HIGH BLEEDING RISK PATIENTS

January 20,2010 | News | BioFreedom
BioFreedom is the only active stent with CE mark for ultra-short 1 month DAPT, in High bleeding Risk (HBR) patients, supported by clinical data from a double-blind randomized controlled trial.
READ MORE

ELDERLY PATIENTS WITH HIGH BLEEDING RISK

February 26,2018 | News | BioFreedom
In the pre-specified elderly subgroup of LEADERS FREE, when considering age over 75 as sole criteria, BioFreedom demonstrated a 0.7% definite or probable stent thrombosis rate at one year.
READ MORE

INNOVATIVE TECHNOLOGIES